Manager - M&A

KEY STAKEHOLDERS: INTERNAL

Business Heads, Finance team, Legal team

KEY STAKEHOLDERS: EXTERNAL

Agencies, Investment Banking Firms

Reporting Structure

Will report to – Deputy General Manager – M&ATeam size - 4

Qualification

Full time MBA in Strategy/ Finance or related fields from Premier B-School

Experience

• 1-3 year of experience with M&A department in another publicly listed company OR transaction advisory experience in an accounting / financial / business M&A advisory firm / Investment bank
• Good communication / presentation skills
  

Critical Qualities

• Analytical and problem-solving capabilities –analyzing business performance, structuring and presenting analysis
• Presentation / communication skills
• Understanding of corporate finance concepts
• Financial analysis and building financial models
• Experience in dealing with external customers and working in cross functional teams
• Knowledge / awareness of issues related to capital markets, regulatory requirements desirable
• Ability to manage multiple tasks
• Attention to detail
  

Key Roles & Responsibilities

• Support identification and evaluation of acquisition opportunities.
• Business evaluation with support from business & other functions
• Analyze financial statements, Build valuation models and prepare business cases.
• Support and co-ordinate due diligence efforts, including assisting business teams, external advisors
• Assist and advice in preparing bid documents, term sheets and other legal documentation, as and when required
• Understand and as required, support development of M&A strategy for relevant businesses–Pharma Solutions, Critical Care, Consumer Healthcare
• Interact with Business teams, I –bankers and management to identify and source acquisition and other related transactions for relevant businesses
• Carry out detailed analysis of potential targets
• Periodic tracking/ analysis of competitive landscape for PEL’s businesses
• Track potential acquisition targets
  

Qualifications

ABOUT US

In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.

Equal employment opportunity

Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

About The Team

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products.PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies. PCC’s complex hospital product portfolio includes inhalation anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anaesthetics, injectable anti-infectives, and other therapies. The Indian Consumer Healthcare business is among the leading players in India in the self-care space, with established brands in the Indian consumer healthcare market. In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, the company received a growth equity investment from the Carlyle Group.